LRF Scientific Leadership and Investment in Innovative Research Highlighted at 2021 American Society of Hematology Annual Meeting

Latest News

LRF Scientific Leadership and Investment in Innovative Research Highlighted at 2021 American Society of Hematology Annual Meeting

LRF Scientific Advisory Board Members Joined by Current and Former Grantees at the 63rd ASH Annual Meeting & Exposition

The Lymphoma Research Foundation (LRF) will return to the American Society of Hematology (ASH) Annual Meeting and Exposition with more than 70 LRF affiliated scientists, including past and present members of LRF’s world-leading Scientific Advisory Board (SAB) and grantees, presenting abstracts at this year’s conference.

Widely regarded as the premier event in malignant and non-malignant hematology, the ASH Annual Meeting, taking place December 11-14, 2021, will provide a critical forum for leading hematologists / oncologists to present their findings to over 20,000 peers. Among the distinguished scientists attending, more than 40 percent of LRF Scholars—participants in LRF’s Lymphoma Scientific Mentoring Program (LSRMP) – will present abstracts at the 2021 ASH Annual Meeting.

In addition to the Foundation’s representation through presentations, nearly 50 percent of LRF grantees (including 94 percent of LRF Scholars) and more than 90 percent of LRF SAB members authored abstracts selected for this year’s meeting alone.  In addition, LRF is represented in 729 abstracts through grantees, Lymphoma Rounds Steering Committee members, Mantle Cell Lymphoma (MCL) Consortium members, and current and past SAB members. 

“The Lymphoma Research Foundation’s commitment to advancing the field of lymphoma research through its investment in the most promising lymphoma research is highlighted through its breadth of reach at ASH,” said Sonali M. Smith, MD, FASCO Chair of the LRF Scientific Advisory Board. “LRF continues to work with the best scientists in the field and invest in the research projects that have the greatest potential to impact and improve the treatment and understanding of lymphoma.”

The 2021 ASH Annual Meeting also featured 24 abstracts and presentations stemming from LRF-funded research and 25 COVID-19-related research authored by LRF-affiliated scientists.

“We are incredibly proud to work with and support scientists who are making strides in advancing lymphoma research,” said Meghan Gutierrez, Chief Executive Officer of the Lymphoma Research Foundation. “We are grateful to have the expertise of our Scientific Advisory Board to guide our research investment and make a meaningful impact on the future of lymphoma research, which is evident in the number of investigators supported by LRF presenting at this year’s ASH Annual Meeting.”

Throughout each ASH Annual Meeting, members of the LRF Senior Leadership Team will be available for comment on ongoing ASH presentations and findings. For requests for comment, please contact Kinya Harte, Director of Communications and Marketing at or 646-465-9107.